Elucid Bioimaging Inc.’s $80 Million Series C Funding Round

Honigman represented Elucid Bioimaging Inc. in the transaction, and Latham and Watkins represented Elevage Medical Technologies.Elucid Bioimaging Inc. announced it has raised $80 million in Series C financing…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here